ertapenem has been researched along with Jaundice, Cholestatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finn, T; Glick, Y; Schattner, A | 1 |
| Abdul-Baki, H; Aoun, E; Chaar, HF; El Hajj, II; Hashash, JG; Kanj, SS; Kyriacos, SB; Mansour, NM; Mroueh, M; Sharara, AI | 1 |
1 trial(s) available for ertapenem and Jaundice, Cholestatic
| Article | Year |
|---|---|
Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ertapenem; Female; Humans; Jaundice, Obstructive; Male; Middle Aged; Sepsis; Young Adult | 2011 |
1 other study(ies) available for ertapenem and Jaundice, Cholestatic
| Article | Year |
|---|---|
Not What It Seems: Obstructive Jaundice in an HIV-Positive Patient.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Diagnosis, Differential; Drainage; Enterococcus; Ertapenem; Female; Fluconazole; Hepatitis B, Chronic; HIV Infections; Humans; Jaundice, Obstructive; Lymphoma; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms | 2021 |